Investing Profile

Jay Lichter

VCInvestor

Managing Director at Avalon Ventures

‌

Your Intro Paths to Jay Lichter

‌

Find Jay Lichter on

Current Investing Position

Investment Range

$1M - $10.0M

Sweet Spot

$5.0M

Investments On Record

Current Fund Size

$116M

Jay Lichter is on these Sector & Stage Rankings

Jay Lichter's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Enlaza Therapeutics	Series AApr 2024$100M SeedOct 2022$61M	$160M
Co-investors: Stephen Squinto (OrbiMed), James N. Topper (Frazier Healthcare Partners), Marcos Milla (Samsara BioCapital)
Arialys Therapeutics	SeedSep 2023$58M	$58M
Janux Therapeutics	Series BApr 2021$130M Series AMar 2021$56M	$180M
Co-investors: Peter Thompson (OrbiMed), Jake Simson (RA Capital)
AristaMD	Series BMar 2020$18M Series AJul 2016$11M	$35M
Co-investors: Payal Agrawal Divakaran (.406 Ventures), John Kuelper (Ascension Ventures)
Avelas Biosciences	Series CAug 2016$20M Series BSep 2014$7M Series BJan 2014$7M Series ADec 2012$8M	$42M
Co-investors: Kevin Kinsella (Avalon Ventures)
Otonomy	Series DApr 2014$49M Series CSep 2013$46M Series AJun 2010$10M	$180M
Co-investors: Chau Khuong (OrbiMed), Bill Harrington (Osage University Partners), Niall O’Donnell (RiverVest), John McKearn (RiverVest), Peter Bisgaard (Pivotal bioVenture Partners), Brian Dovey (Domain Associates), Heather Preston
Aratana Therapeutics	Series BDec 2011$15M Series AJan 2011$20M	$35M
Co-investors: Steven St. Peter (T1D Fund), Ron Meeusen (Cultivian Sandbox Ventures)